Latest intravenous therapy Stories
Emerging-company finance conference selects Colorado digital health and information company. BOULDER, Colo.
SILVER SPRING, Md., Dec. 31, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the signing of an agreement with DEKA Research & Development Corp.
SILVER SPRING, Md., Dec. 24, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc.
BCC Research (http://www.bccresearch.com) anticipates that increasing competition, patent expirations and evolving customer needs will influence
HELSINKI and ATLANTA, December 10, 2014 /PRNewswire/ -- Optomeditech Ltd (http://www.optomeditech.com ) today announced a $ 2.5 million funding round led by Lifeline Ventures
LONDON, Nov. 20, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for intravenous therapy and vein access was $19.3 billion in 2013.
NEWARK, Calif., Nov.
The Colorado Capital Conference showcases digital health and information company. Boulder, Colo.
While the U.S.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
- A young chicken: also used as a pet name for children.